Quality of Life, Work Appear to Improve for Patients Taking Humira in China

Quality of Life, Work Appear to Improve for Patients Taking Humira in China

284014

Quality of Life, Work Appear to Improve for Patients Taking Humira in China

Treatment with Humira (adalimumab) over six months significantly reduced symptoms and improved physical function, quality of life, and work productivity in ankylosing spondylitis (AS) patients, a Chinese study finds. The study, “Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China,” was published in the journal Frontiers in Public Health. AS is characterized by inflammation in the joints of the spine, causing lower back pain and…

You must be logged in to read/download the full post.